Inspire Medical Systems (INSP) Cash from Operations Growth (3y) (2020 - 2026)
Inspire Medical Systems (INSP) Cash from Operations Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 0.50% |
| 10 | Inspire Medical Systems | 1.43 Bn | 1.15 Bn | 176.91 Mn | 126.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126.11% |
| Dec 31, 2025 | 39.64% |
| Sep 30, 2025 | 83.99% |
| Jun 30, 2025 | 34.82% |
| Mar 31, 2025 | 19.29% |
| Dec 31, 2024 | 355.09% |
| Sep 30, 2024 | 439.11% |
| Jun 30, 2024 | 80.24% |
| Mar 31, 2024 | 41.81% |
| Dec 31, 2023 | 83.72% |
| Sep 30, 2023 | 34.04% |
| Jun 30, 2023 | 30.09% |
| Mar 31, 2023 | 55.03% |
| Dec 31, 2022 | 72.93% |
| Sep 30, 2022 | 79.02% |
| Jun 30, 2022 | 22.69% |
| Mar 31, 2022 | -5.22% |
| Dec 31, 2021 | 31.68% |
| Sep 30, 2021 | 54.35% |
| Jun 30, 2021 | -18.14% |